Blunt MD - Search Results

1

NK Cells in the Lymph Nodes and Their Role in Anti-Tumour Immunity.

Graham LV, Khakoo SI, Blunt MD. Graham LV, et al. Among authors: blunt md. Biomedicines. 2024 Jul 25;12(8):1667. doi: 10.3390/biomedicines12081667. Biomedicines. 2024. PMID: 39200132 Free PMC article. Review.

2

The role of NK cells in oncolytic viral therapy: a focus on hepatocellular carcinoma.

Warricker F, Khakoo SI, Blunt MD. Warricker F, et al. Among authors: blunt md. J Transl Genet Genom. 2021;5:304-322. doi: 10.20517/jtgg.2021.27. Epub 2021 Aug 4. J Transl Genet Genom. 2021. PMID: 34888493 Free PMC article.

3

A novel antibody combination to identify KIR2DS2^high natural killer cells in KIR2DL3/L2/S2 heterozygous donors.

Blunt MD, Rettman P, Bastidas-Legarda LY, Fulton R, Capizzuto V, Naiyer MM, Traherne JA, Khakoo SI. Blunt MD, et al. HLA. 2019 Jan;93(1):32-35. doi: 10.1111/tan.13413. HLA. 2019. PMID: 30381896 Free PMC article.

4

Activating killer cell immunoglobulin-like receptors: Detection, function and therapeutic use.

Blunt MD, Khakoo SI. Blunt MD, et al. Int J Immunogenet. 2020 Feb;47(1):1-12. doi: 10.1111/iji.12461. Epub 2019 Nov 22. Int J Immunogenet. 2020. PMID: 31755661 Review.

5

Constitutive Activation of Natural Killer Cells in Primary Biliary Cholangitis.

Hydes TJ, Blunt MD, Naftel J, Vallejo AF, Seumois G, Wang A, Vijayanand P, Polak ME, Khakoo SI. Hydes TJ, et al. Among authors: blunt md. Front Immunol. 2019 Nov 15;10:2633. doi: 10.3389/fimmu.2019.02633. eCollection 2019. Front Immunol. 2019. PMID: 31803181 Free PMC article.

6

Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors.

Rettman P, Blunt MD, Fulton RJ, Vallejo AF, Bastidas-Legarda LY, España-Serrano L, Polak ME, Al-Shamkhani A, Retiere C, Khakoo SI. Rettman P, et al. Among authors: blunt md. J Immunother Cancer. 2021 May;9(5):e001912. doi: 10.1136/jitc-2020-001912. J Immunother Cancer. 2021. PMID: 34016721 Free PMC article.

7

Selinexor Enhances NK Cell Activation Against Malignant B Cells via Downregulation of HLA-E.

Fisher JG, Walker CJ, Doyle AD, Johnson PW, Forconi F, Cragg MS, Landesman Y, Khakoo SI, Blunt MD. Fisher JG, et al. Among authors: blunt md. Front Oncol. 2021 Dec 1;11:785635. doi: 10.3389/fonc.2021.785635. eCollection 2021. Front Oncol. 2021. PMID: 34926302 Free PMC article.

8

KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity.

Blunt MD, Vallejo Pulido A, Fisher JG, Graham LV, Doyle ADP, Fulton R, Carter MJ, Polak M, Johnson PWM, Cragg MS, Forconi F, Khakoo SI. Blunt MD, et al. J Immunol. 2022 Jul 15;209(2):379-390. doi: 10.4049/jimmunol.2101139. Epub 2022 Jun 29. J Immunol. 2022. PMID: 35768150 Free PMC article.

9

Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer.

Fisher JG, Doyle ADP, Graham LV, Khakoo SI, Blunt MD. Fisher JG, et al. Among authors: blunt md. Vaccines (Basel). 2022 Nov 23;10(12):1993. doi: 10.3390/vaccines10121993. Vaccines (Basel). 2022. PMID: 36560403 Free PMC article. Review.

10

XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression.

Fisher JG, Doyle ADP, Graham LV, Sonar S, Sale B, Henderson I, Del Rio L, Johnson PWM, Landesman Y, Cragg MS, Forconi F, Walker CJ, Khakoo SI, Blunt MD. Fisher JG, et al. Among authors: blunt md. Leukemia. 2023 Oct;37(10):2036-2049. doi: 10.1038/s41375-023-01984-z. Epub 2023 Aug 1. Leukemia. 2023. PMID: 37528310 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters